Involvement of the dorsal subiculum and rostral basolateral amygdala in cocaine cue extinction learning in rats.
Memory system circuitry may regulate how cues associated with cocaine are extinguished, and understanding neurosubstrates of extinction may lead to the development of improved treatment strategies for cocaine addiction. Sites within the hippocampus and amygdala were investigated for their role in regulating cocaine cue extinction learning. Initially, rats were trained to self-administer cocaine under a second-order reinforcement schedule (cocaine and cocaine cues present) followed by a 2-week abstinence period. Using lidocaine, rats next underwent bilateral inactivation of the dorsal subiculum (dSUB) or rostral basolateral amygdala (rBLA), asymmetric inactivation of the dSUB and rBLA, unilateral inactivation of the dSUB or rBLA, or ipsilateral inactivation of the dSUB and rBLA prior to cocaine cue extinction training sessions (only cocaine cues present) on two consecutive days. Relative to vehicle, bilateral and asymmetric lidocaine treatments in the dSUB and rBLA slowed cocaine cue extinction learning. Specifically, vehicle-treated rats exhibited a significantly larger difference in responding from Day 1 to Day 2 of extinction training than lidocaine-treated rats. In comparison, unilateral or ipsilateral lidocaine treatments in the dSUB and rBLA did not slow cocaine cue extinction learning. Rats treated with lidocaine and vehicle exhibited a similar difference in responding from Day 1 to Day 2 of extinction training. These results indicate that sites within the hippocampus and amygdala need to be functionally active simultaneously in at least one brain hemisphere for acquisition of cocaine cue extinction learning. These results further suggest that a serial circuit within each hemisphere mediates acquisition of cocaine cue extinction learning.
Laboratory of Behavioral Neuroscience, Department of Psychology, Boston University, Boston, MA 02215, USA.
Jonathan J
JJ
Szalay
Nicole D
ND
Morin
Kathleen M
KM
Kantak
D000679:Amygdala / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology*; D000818:Animals; D003042:Cocaine / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology; D003463:Cues; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology; D005108:Extinction, Psychological / Q000502:physiology*; D006624:Hippocampus / Q000033:anatomy & histology / Q000187:drug effects* / Q000502:physiology*; D007858:Learning / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009415:Nerve Net / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
D018765:Dopamine Uptake Inhibitors; D003042:Cocaine
Eur J Neurosci. 2006 Dec;24(11):3285-98
17156389
NIDA Res Monogr. 1993;137:73-95
8289929
J Neurosci. 2010 Aug 4;30(31):10526-33
20685995
Psychopharmacology (Berl). 1998 Dec;140(3):331-44
9877013
Brain Res. 1995 Jan 23;670(1):75-81
7719727
Pharmacol Biochem Behav. 2008 Sep;90(3):481-91
18499239
Eur J Neurosci. 2003 May;17(9):1964-72
12752796
Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10718-23
16020527
Neuropsychopharmacology. 2010 Jan;35(2):357-67
19741593
Curr Neurovasc Res. 2004 Jan;1(1):55-60
16181066
J Comp Neurol. 1998 Apr 13;393(3):284-97
9548550
Ann N Y Acad Sci. 2007 Dec;1121:576-97
17846151
Brain Res Brain Res Rev. 2001 Dec;38(1-2):247-89
11750934
Eur J Neurosci. 2007 Jul;26(2):487-98
17650119
Brain Res. 1995 Apr 3;676(1):183-8
7796168
Neuroscience. 1987 Oct;23(1):103-20
3683859
Behav Brain Res. 2004 May 5;151(1-2):225-38
15084439
Ann N Y Acad Sci. 1999 Jun 29;877:49-63
10415642
Psychopharmacology (Berl). 2002 Oct;163(3-4):327-44
12373434
Eur J Neurosci. 2006 May;23(10):2809-13
16817884
Neuropsychopharmacology. 2007 Sep;32(9):1929-40
17213844
Eur J Neurosci. 1990;2(8):718-725
12106290
Psychopharmacology (Berl). 2002 May;161(3):278-87
12021831
Psychopharmacology (Berl). 1995 Sep;121(2):150-7
8545519
J Neurosci. 2002 Feb 1;22(3):1126-36
11826141
Brain Res. 1996 Aug 19;730(1-2):32-9
8883885
Neurobiol Learn Mem. 1998 Mar;69(2):163-203
9619995
Nature. 2001 Jul 12;412(6843):141-2
11449260
Addict Behav. 1990;15(4):355-65
2248109
J Neurosci Methods. 1997 Jun 6;74(1):17-26
9210571
Neuropsychopharmacology. 2005 Feb;30(2):296-309
15483559
Neurobiol Learn Mem. 2006 Sep;86(2):123-32
16458544
Eur J Neurosci. 2002 Apr;15(8):1363-70
11994130
J Comp Neurol. 1999 Jan 11;403(2):229-60
9886046
J Neurosci. 2005 Sep 28;25(39):8978-87
16192388
Psychopharmacology (Berl). 1996 Jun;125(4):355-60
8826540
Behav Neurosci. 1995 Aug;109(4):642-7
7576208
Psychopharmacology (Berl). 1993;112(2-3):163-82
7871016
Neurobiol Learn Mem. 1997 Nov;68(3):285-316
9398590
J Comp Neurol. 2006 May 20;496(3):349-68
16566004
Neuroscience. 2003;117(2):477-83
12614687
Neuroscience. 2007 Jun 8;146(4):1484-94
17449185
Hippocampus. 2009 Sep;19(9):800-16
19235229
Brain Struct Funct. 2008 Sep;213(1-2):215-27
18488248
Nat Neurosci. 2004 Apr;7(4):389-97
15034590
Brain Res. 1997 Dec 19;778(2):418-29
9459563
Eur J Neurosci. 1997 Jan;9(1):76-83
9042571
Eur J Pharmacol. 2005 Dec 5;526(1-3):140-6
16253228
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11642-7
10500230
Eur J Neurosci. 2006 Jul;24(1):261-9
16882022
J Neurosci. 1992 Mar;12(3):854-63
1347562